Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Model Organisms Center (SHSE:688265) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shanghai Model Organisms Center EBITDA Margin % Related Terms
Shanghai Model Organisms Center EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Model Organisms Center EBITDA Margin % Chart
SHSE:688265 vs VRTX, REGN, RVMD: EBITDA Margin % Comparison
For the Biotechnology subindustry, Shanghai Model Organisms Center's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Model Organisms Center EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Model Organisms Center's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Model Organisms Center's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Model Organisms Center (SHSE:688265) has a EBITDA Margin % of 0.95% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai Model Organisms Center and its competitors. This is 95% below median its historical median of 18.24. According to the industry distribution chart, Shanghai Model Organisms Center ranks #253 out of 940 companies in the Biotechnology industry, placing it in the top 26.9%.
Is Shanghai Model Organisms Center's EBITDA Margin % too high?
Shanghai Model Organisms Center's current EBITDA Margin % of 0.95% is 95% below median its 10-year median of 18.24. Based on the distribution chart, Shanghai Model Organisms Center ranks #253 out of 940 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai Model Organisms Center has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Model Organisms Center's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Model Organisms Center ranks #253 out of 940 companies for EBITDA Margin %. This puts Shanghai Model Organisms Center in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai Model Organisms Center and its competitors. Shanghai Model Organisms Center's current EBITDA Margin % is 0.95%, which is 95% below median its own 10-year median of 18.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Model Organisms Center stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Model Organisms Center (SHSE:688265) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥47.95, compared to a current price of ¥31.90 — trading 33.5% below its estimated fair value. The current EBITDA Margin % is 0.95%, which is 95% below median its 10-year median of 18.24. Shanghai Model Organisms Center's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shanghai Model Organisms Center (SHSE:688265), the current EBITDA Margin % is 0.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Model Organisms Center (SHSE:688265) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Model Organisms Center stock appears to be undervalued.
The current stock price of ¥31.90 is trading 33.5% below its estimated GF Value™ of ¥47.95.
GuruFocus considers Shanghai Model Organisms Center to be Significantly Undervalued.
Key valuation signals for SHSE:688265:
EBITDA Margin %: 0.95% (95% below median its 10-year median of 18.24)
GF Value™: ¥47.95 vs. price of ¥31.90 (33.5% below fair value)
No single metric tells the full story. See the SHSE:688265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Model Organisms Center Business Description
Shanghai Model Organisms Center Inc is engaged in model organisms and is dedicated to gene editing and life decoding. It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery.
78GF Score
Get the complete analysis for SHSE:688265
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688265 has been successfully added to your 
